Insulet (PODD) EBT Margin (2010 - 2026)
Insulet's (PODD) quarterly EBT Margin came in at 14.81% in Q2 2026, up 1043.0% on a YoY basis from 1.3% in Q2 2025, and little changed quarter-over-quarter from 14.84% in Q1 2026.
Powered by 
Analysis
Insulet (PODD) EBT Margin (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported EBT Margin for 17 consecutive years, with 14.81% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 1043.0% year-over-year to 14.81%; the trailing twelve-month figure through Jun 2026 stood at 16.2% (up 472.0% YoY), and the FY2025 full-year result was 12.54%, down 195.0% from the prior year.
- EBT Margin was little changed at 14.81% in Q2 2026 per PODD's latest filing, from 14.84% in the prior quarter.
- Across five years, EBT Margin topped out at 21.17% in Q4 2023 and bottomed at 12.06% in Q2 2022.
- Historically, EBT Margin has averaged 10.24% across 5 years, with a median of 11.44% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBT Margin tumbled 719 bps in 2022, then surged 1925 bps in 2023.
- Over 5 years, EBT Margin stood at 6.03% in 2022, then jumped by 251 bps to 21.17% in 2023, then fell by 12 bps to 18.64% in 2024, then dropped by 4 bps to 17.89% in 2025, then retreated by 17 bps to 14.81% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 14.81%, 14.84%, and 17.89% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 18.32% |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 14.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.81% |
| Mar 31, 2026 | 14.84% |
| Dec 31, 2025 | 17.89% |
| Sep 30, 2025 | 17.39% |
| Jun 30, 2025 | 4.38% |
| Mar 31, 2025 | 8.47% |
| Dec 31, 2024 | 18.64% |
| Sep 30, 2024 | 15.24% |
| Jun 30, 2024 | 10.46% |
| Mar 31, 2024 | 12.43% |
| Dec 31, 2023 | 21.17% |
| Sep 30, 2023 | 12.41% |
| Jun 30, 2023 | 7.19% |
| Mar 31, 2023 | 6.87% |
| Dec 31, 2022 | 6.03% |
| Sep 30, 2022 | -1.67% |
| Jun 30, 2022 | -12.06% |
| Mar 31, 2022 | 9.92% |
| Dec 31, 2021 | 10.85% |
| Sep 30, 2021 | 5.52% |